188 related articles for article (PubMed ID: 32232968)
1. Preservative-free versus preserved glaucoma eye drops and occurrence of glaucoma surgery. A retrospective study based on the French national health insurance information system, 2008-2016.
Chamard C; Larrieu S; Baudouin C; Bron A; Villain M; Daien V
Acta Ophthalmol; 2020 Nov; 98(7):e876-e881. PubMed ID: 32232968
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety evaluation of benzalkonium chloride preserved eye-drops compared with alternatively preserved and preservative-free eye-drops in the treatment of glaucoma: a systematic review and meta-analysis.
Hedengran A; Steensberg AT; Virgili G; Azuara-Blanco A; Kolko M
Br J Ophthalmol; 2020 Nov; 104(11):1512-1518. PubMed ID: 32051133
[TBL] [Abstract][Full Text] [Related]
3. Preservative-free versus preserved latanoprost eye drops in patients with open-angle glaucoma or ocular hypertension.
Aptel F; Choudhry R; Stalmans I
Curr Med Res Opin; 2016 Aug; 32(8):1457-63. PubMed ID: 27310103
[TBL] [Abstract][Full Text] [Related]
4. Preservative-free treatment in glaucoma: who, when, and why.
Stalmans I; Sunaric Mégevand G; Cordeiro MF; Hommer A; Rossetti L; Goñi F; Heijl A; Bron A
Eur J Ophthalmol; 2013; 23(4):518-25. PubMed ID: 23483513
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication.
Pisella PJ; Pouliquen P; Baudouin C
Br J Ophthalmol; 2002 Apr; 86(4):418-23. PubMed ID: 11914211
[TBL] [Abstract][Full Text] [Related]
6. Selective laser trabeculoplasty versus drops for newly diagnosed ocular hypertension and glaucoma: the LiGHT RCT.
Gazzard G; Konstantakopoulou E; Garway-Heath D; Garg A; Vickerstaff V; Hunter R; Ambler G; Bunce C; Wormald R; Nathwani N; Barton K; Rubin G; Morris S; Buszewicz M
Health Technol Assess; 2019 Jun; 23(31):1-102. PubMed ID: 31264958
[TBL] [Abstract][Full Text] [Related]
7. Corneal damage and its recovery after instillation of preservative-free versus preserved latanoprost eye drops.
Inoue D; Mohamed YH; Uematsu M; Kitaoka T
Cutan Ocul Toxicol; 2020 Jun; 39(2):158-164. PubMed ID: 32295438
[No Abstract] [Full Text] [Related]
8. Efficacy and safety of preservative-free timolol 0.1% gel in open-angle glaucoma and ocular hypertension in treatment-naïve patients and patients intolerant to other hypotensive medications.
Lazreg S; Merad Z; Nouri MT; Garout R; Derdour A; Ghroud N; Kherroubi R; Meziane M; Belkacem S; Ouhadj O; Baudouin C; Tiar M
J Fr Ophtalmol; 2018 Dec; 41(10):945-954. PubMed ID: 30477719
[TBL] [Abstract][Full Text] [Related]
9. Preservative exposure and surgical outcomes in glaucoma patients: The PESO study.
Boimer C; Birt CM
J Glaucoma; 2013 Dec; 22(9):730-5. PubMed ID: 23524856
[TBL] [Abstract][Full Text] [Related]
10. Prescription trends for preservative free glaucoma medication in a public health system.
Pérez-García P; Burgos-Blasco B; Morales-Fernández L; Fernández-Ruiz-Morón A; Gómez-Calleja V; Oribio-Quinto C; Collado-Vincueria I; Garcia-Feijoo J; Martinez-de-la-Casa JM
Eur J Ophthalmol; 2024 Jan; 34(1):193-203. PubMed ID: 37070183
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and tolerability of preservative-free eye drops containing a fixed combination of dorzolamide and timolol in glaucoma patients.
Renieri G; Führer K; Scheithe K; Lorenz K; Pfeiffer N; Thieme H
J Ocul Pharmacol Ther; 2010 Dec; 26(6):597-603. PubMed ID: 20977366
[TBL] [Abstract][Full Text] [Related]
12. Switch from BAK-preserved to preservative-free latanoprost decreases anterior chamber flare in POAG patients.
Kestelyn PA; Kestelyn PG; De Bacquer D; Stevens AM
Int Ophthalmol; 2019 Jan; 39(1):105-109. PubMed ID: 29274019
[TBL] [Abstract][Full Text] [Related]
13. An in vivo confocal microscopy analysis of effects of topical antiglaucoma therapy with preservative on corneal innervation and morphology.
Martone G; Frezzotti P; Tosi GM; Traversi C; Mittica V; Malandrini A; Pichierri P; Balestrazzi A; Motolese PA; Motolese I; Motolese E
Am J Ophthalmol; 2009 Apr; 147(4):725-735.e1. PubMed ID: 19181302
[TBL] [Abstract][Full Text] [Related]
14. [Ocular Surface Evaluation in Patients Treated with Prostaglandin Analogues Considering Preservative Agent].
Mlčáková E; Mlčák P; Karhanová M; Langová K; Marešová K
Cesk Slov Oftalmol; 2016; 72(4):120-127. PubMed ID: 27860477
[TBL] [Abstract][Full Text] [Related]
15. [The influence of ocular surface diseases in the management of glaucoma].
Van Went C; Brasnu E; Hamard P; Baudouin C; Labbé A
J Fr Ophtalmol; 2011 Apr; 34(4):230-7. PubMed ID: 21439676
[TBL] [Abstract][Full Text] [Related]
16. Ocular Surface Disease in Glaucoma: Effect of Polypharmacy and Preservatives.
Ramli N; Supramaniam G; Samsudin A; Juana A; Zahari M; Choo MM
Optom Vis Sci; 2015 Sep; 92(9):e222-6. PubMed ID: 25730335
[TBL] [Abstract][Full Text] [Related]
17. Influence of Treating Ocular Surface Disease on Intraocular Pressure in Glaucoma Patients Intolerant to Their Topical Treatments: A Report of 10 Cases.
Dubrulle P; Labbé A; Brasnu E; Liang H; Hamard P; Meziani L; Baudouin C
J Glaucoma; 2018 Dec; 27(12):1105-1111. PubMed ID: 30489502
[TBL] [Abstract][Full Text] [Related]
18. Effect of changing from preserved prostaglandins to preservative-free tafluprost in patients with glaucoma on tear film thickness.
Hommer A; Schmidl D; Kromus M; Bata AM; Fondi K; Werkmeister RM; Baar C; Schmetterer L; Garhöfer G
Eur J Ophthalmol; 2018 Jul; 28(4):385-392. PubMed ID: 29592773
[TBL] [Abstract][Full Text] [Related]
19. [Advances in preservative-free glaucoma drops].
Stefan C; Pop A; Cojocaru I
Oftalmologia; 2011; 55(2):3-6. PubMed ID: 21888063
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of preservative-free latanoprost eyedrops, compared with BAK-preserved latanoprost in patients with ocular hypertension or glaucoma.
Rouland JF; Traverso CE; Stalmans I; Fekih LE; Delval L; Renault D; Baudouin C;
Br J Ophthalmol; 2013 Feb; 97(2):196-200. PubMed ID: 23203707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]